Quick Answer
VYCOR MEDICAL INC reported R&D Expense of $10.0 thousand for fiscal year 2025.
VYCOR MEDICAL INC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $10.0K | -35.0% |
| 2024 | $15.3K | -32.1% |
| 2023 | $22.6K | +48.8% |
| 2021 | $15.2K | +402.8% |
| 2017 | $3.0K | -36.4% |
| 2016 | $4.7K | -93.4% |
| 2015 | $71.5K | +3.5% |
| 2014 | $69.1K | +29.3% |
| 2013 | $53.5K | -57.6% |
| 2012 | $126.0K | +9.0% |
| 2011 | $115.7K | +660.6% |
| 2010 | $15.2K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| June 30, 2025 | $4.2K | +85.6% | -27.1% |
| March 31, 2025 | $5.8K | — | -10.3% |
| September 30, 2024 | $6.4K | -11.4% | +183.9% |
| June 30, 2024 | $2.3K | -70.0% | -68.8% |
| September 30, 2023 | $7.2K | — | -4.0% |
| June 30, 2023 | $7.5K | — | +37.1% |
| March 31, 2023 | $5.5K | — | +201.8% |
| September 30, 2021 | $1.8K | — | -53.6% |
- VYCOR MEDICAL INC showed a decrease of -35.0% in R&D Expense compared to the prior fiscal year.
- Over the 2010–2025 period, VYCOR MEDICAL INC’s r&d expense has declined by 34.5% (from $15.2 thousand to $10.0 thousand).
- The most recent figure is from VYCOR MEDICAL INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: